Lakefront Biotherapeutics (LKFT)

NASDAQ:LKFT

US Market

LKFT

Lakefront Biotherapeutics

RESEARCH TOOLSreports

Want to see LKFT full AI Analyst Report?

Lakefront Biotherapeutics (LKFT) Ownership - Who Owns Lakefront Biotherapeutics?

549 Followers

Lakefront Biotherapeutics (LKFT) Ownership Overview

1.72% Mutual Funds

41.89% Other Institutional Investors

0.63% ETFs

55.76% Public Companies and

Individual Investors

The ownership structure of Lakefront Biotherapeutics (LKFT) stock is a mix of institutional, retail, and individual investors. Approximately 44.24% of the company’s stock is owned by Institutional Investors, and 55.76% is owned by Public Companies and Individual Investors.

The ownership structure of Lakefront Biotherapeutics (LKFT) stock is a mix of institutional, retail, and individual investors. Approximately 42.52% of the company’s stock is owned by Institutional Investors, 1.72% is owned by Insiders, and 55.76% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$750

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	714,747	Institution	1.08%	20,027,211
	287,557	Institution	0.44%	8,057,347
	108,500	Institution	0.16%	3,040,170
	94,266	Institution	0.14%	2,641,333
	94,152	Institution	0.14%	2,638,139
	80,106	Institution	0.12%	2,244,570
	67,374	Institution	0.10%	1,887,819
Theofanis Kolokotrones	50,500	Institution	0.08%	1,415,010
	38,679	Institution	0.06%	1,083,786
	32,701	Institution	0.05%	916,282

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	714,747	Institution	1.08%	20,027,211
	108,500	Institution	0.16%	3,040,170
	94,266	Institution	0.14%	2,641,333
	94,152	Institution	0.14%	2,638,139
	80,106	Institution	0.12%	2,244,570
	32,701	Institution	0.05%	916,282
	7,851	Institution	0.01%	219,985
	1,419	Institution	<0.01%	39,760

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	268,801	Institution	0.41%	7,531,804
ALPS Medical Breakthroughs ETF	67,374	Institution	0.10%	1,887,819
Avantis International Equity ETF	30,449	Institution	0.05%	855,921
ActivePassive International Equity ETF	18,305	Institution	0.03%	514,554
iShares NASDAQ US Biotechnology UCITS ETF	10,545	Institution	0.02%	296,420
Avantis International Small Cap Equity ETF	7,042	Institution	0.01%	197,951
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD	1,848	Institution	<0.01%	51,947
Invesco Nasdaq Biotechnology ETF	794	Institution	<0.01%	21,843
American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD	569	Institution	<0.01%	15,995
Avantis Global Equity Ucits ETF	569	Institution	<0.01%	15,995

FAQ

Who Owns Lakefront Biotherapeutics (LKFT)?

Currently, no data Available

What percentage of Lakefront Biotherapeutics (LKFT) stock is held by institutional investors?

According to the latest TipRanks data, approximately 41.89% of Lakefront Biotherapeutics (LKFT) stock is held by institutional investors.

What percentage of Lakefront Biotherapeutics (LKFT) stock is held by retail investors?

According to the latest TipRanks data, approximately 55.76% of Lakefront Biotherapeutics (LKFT) stock is held by retail investors.

Who owns the most shares of Lakefront Biotherapeutics (LKFT)?

COLUMBIA FUNDS SERIES TRUST owns the most shares of Lakefront Biotherapeutics (LKFT).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.